Month: January 2020

Annovis announces IPO results; Conatus merges with Histogen; Novartis discontinues its generic journey

Business Consultant, Pharma Consultant, Pharma news

A Philadelphia-based pharmaceutical, Annovis Bio, has raised USD12 million by listing its 2 million shares at USD 6 each. The company has...

Read More

Potential of Digital therapeutics and increasing CVDs

Business Consultant, Pharma Consultant, Snippets

The 21st century has been a remarkable century for humankind, as a lot of innovation, research and development has taken place in the field...

Read More

Acceleron Pharma’s drug sotatercept touches the phase 2 mark; GT Medical receives nod for GammaTile; New treatment strategy for Parkinson’s disease

Business Consultant, Pharma Consultant, Pharma news

The drug, sotatercept of Acceleron Pharma, touches the phase 2 mark Acceleron Pharma, a clinical-stage biopharmaceutical company based in...

Read More

Tepezza receives approval; a new way to treat Alzheimer’s

Business Consultant, Pharma Consultant, Pharma news

Horizon Therapeutics has become the first company to receive the regulatory approval of its drug Tepezza for the cure of Thyroid Eye...

Read More

Polypills: Can they offer a potential approach to treat CVDs?

Business Consultant, Pharma Consultant, Snippets

Cardiovascular disease (CVD), such as heart attack and stroke, is a leading cause of deaths and hampering the quality of life in the US....

Read More
Close